4//SEC Filing
Orford Keith 4
Accession 0000899243-19-007526
CIK 0001496671other
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 4:10 PM ET
Size
4.9 KB
Accession
0000899243-19-007526
Insider Transaction Report
Form 4
Orford Keith
SR. VP, CLINICAL DEVELOPMENT
Transactions
- Sale
Common Stock
2019-03-11$6.00/sh−1,565$9,390→ 11,249 total
Footnotes (2)
- [F1]Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on April 25, 2018.
- [F2]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on December 10, 2018.
Documents
Issuer
Calithera Biosciences, Inc.
CIK 0001496671
Entity typeother
Related Parties
1- filerCIK 0001670740
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 4:10 PM ET
- Size
- 4.9 KB